The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-35943-0
PubMed Identifier: 36765050
Publication URI: http://europepmc.org/abstract/MED/36765050
Type: Journal Article/Review
Volume: 14
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723